www.mirror.co.uk · · GB
Dying Mum Begs See Daughters
News Analysis — AI Analysis
Original analysis generated by News Analysis. This is our own commentary on the story, not the publisher's article text.
A woman diagnosed with advanced breast cancer is advocating for the NHS to approve and provide access to the life-extending drug Enhertu. She argues that the denial of this treatment, which is available in other countries, is depriving her and thousands of others of vital time with their families. The article highlights that Breast Cancer Now is campaigning for urgent action after recent changes to NHS spending limits.
Key points
- The patient, Jess Duggan, pleaded for Enhertu to be made available on the NHS to extend life for women with breast cancer.
- Enhertu is a targeted treatment for metastatic breast cancer that was previously rejected by the NHS due to cost in 2024.
- Jess notes that the drug is free in Scotland and several other European nations, but currently denied in England, Wales, and Northern Ireland.
- The charity Breast Cancer Now is urging pharmaceutical companies, NICE, and NHS England to reach an agreement for immediate approval.
- Jess's diagnosis was secondary breast cancer affecting her lymphatic system, bones, and lungs, following a period of remission.
Claims assessed
- VerifiableThe drug Enhertu is a targeted treatment licensed for metastatic breast cancer that cannot be surgically removed or has spread.
- VerifiableJess Duggan fears she has only weeks left to live and wants more time with her children, particularly to see her daughter's prom.
- VerifiableThe drug Enhertu was rejected for NHS use in 2024 because it was deemed too expensive.
Missing context
The article does not provide details regarding the current NHS spending limits or the specific policy changes in April that are creating this 'fresh opportunity' for drug approval. It also lacks information on the potential cost-effectiveness data that might be used to negotiate a deal with pharmaceutical companies.
Topic context
Related topics
The full article is on the original publisher site.
AI insight
AI-generatedThe article contains personal and emotional content (a dying mother's plea) and does not describe any commercial, industrial, or financial event that affects commodity prices, supply chains, corporate margins, or investment cycles.
Related stories
tribune.com.pk
Development Outlay Cut Despite GDP Growth
aljazeera.com
Trump Says US Strike Killed Tren De Aragua Gang Boss With Venezuela Help
us.cnn.com
Fertility Decline Smartphone Study
theguardian.com
Drug Diversion Schemes Reoffending Rates Police
witneygazette.co.uk